{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:12:57Z","timestamp":1789351977519,"version":"build-2803163510"},"reference-count":83,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.addr.2004.02.004","type":"journal-article","created":{"date-parts":[[2004,4,10]],"date-time":"2004-04-10T09:39:29Z","timestamp":1081589969000},"page":"1367-1382","source":"Crossref","is-referenced-by-count":93,"title":["Current status and potential application of ISCOMs in veterinary medicine"],"prefix":"10.1016","volume":"56","author":[{"given":"Bror","family":"Morein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Fei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izzeldin","family":"Abusugra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2004.02.004_BIB1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1101\/sqb.1999.64.429","article-title":"Innate immune induction of the adaptive immune response","volume":"64","author":"Medzhitov","year":"1999","journal-title":"Cold Spring Harbor Symp. Quant. Biol."},{"key":"10.1016\/j.addr.2004.02.004_BIB2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/276715a0","article-title":"Effective subunit vaccines against an enveloped animal virus","volume":"276","author":"Morein","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.addr.2004.02.004_BIB3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1471-4906(02)02316-5","article-title":"Formyl-peptide receptors revisited","volume":"23","author":"Le","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB4","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/308457a0","article-title":"ISCOM, a novel structure for antigenic presentation of membrane proteins from enveloped viruses","volume":"308","author":"Morein","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.addr.2004.02.004_BIB5","first-page":"1","article-title":"Proceddes pour accroitre la production des antitoxines","volume":"40","author":"Ramon","year":"1926","journal-title":"Ann. Inst. Pasteur"},{"key":"10.1016\/j.addr.2004.02.004_BIB6","first-page":"1","article-title":"A study of the isolation and characterization of the saponin Quil A. Evaluation of its adjuvant activity with special reference to the application in the vaccination of cattle against foot-and-mouse disease","volume":"69","author":"Dalsgaard","year":"1978","journal-title":"Acta Vet. Scand. Suppl."},{"key":"10.1016\/j.addr.2004.02.004_BIB7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0169-409X(01)00165-X","article-title":"Immunostimulating complexes (ISCOMs) for nasal vaccination","volume":"51","author":"Hu","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2004.02.004_BIB8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1574-695X.2001.tb00506.x","article-title":"Different respiratory syncytial virus and Quillaja saponin formulations induce murine peritoneal cells to express different proinflammatory cytokine profiles","volume":"31","author":"Hu","year":"2001","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.addr.2004.02.004_BIB9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4049\/jimmunol.146.2.431","article-title":"Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex","volume":"146","author":"Kensil","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-1-4899-1675-4_2","article-title":"ISCOMs and immunostimulation with viral antigens","volume":"15","author":"H\u00f6glund","year":"1989","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.addr.2004.02.004_BIB11","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/0264-410X(95)00105-A","article-title":"Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix","volume":"13","author":"Ronnberg","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2004.02.004_BIB12","first-page":"1485","article-title":"Fluorescent labelling of virus, bacteria and ISCOMs: in vivo systemic and mucosal localisation patterns","volume":"371B","author":"Claassen","year":"1995","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.addr.2004.02.004_BIB13","first-page":"G554","article-title":"Transport of an influenza virus vaccine formulation (ISCOM) in Caco-2 cells","volume":"270","author":"Lazorova","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.addr.2004.02.004_BIB14","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/S0264-410X(99)00128-0","article-title":"ISCOMs with different Quillaja saponin components differ in their immunomodulating activities","volume":"17","author":"Johansson","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2004.02.004_BIB15","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/S0264-410X(99)00052-3","article-title":"ISCOM and ISCOM-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretions","volume":"17","author":"Ekstrom","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2004.02.004_BIB16","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.4049\/jimmunol.167.6.3398","article-title":"CTA1-DD-immune stimulating complexes: a novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen","volume":"167","author":"Mowat","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0022-1759(90)90208-D","article-title":"Increased immunogenicity of a non-amphipathic protein (BSA) after inclusion into ISCOMs","volume":"128","author":"Morein","year":"1990","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.addr.2004.02.004_BIB18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0264-410X(89)90164-3","article-title":"Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120)","volume":"7","author":"Pyle","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2004.02.004_BIB19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF00198460","article-title":"Protection of mice against an influenza virus infection by oral vaccination with viral nucleoprotein incorporated into immunostimulating complexes","volume":"183","author":"Scheepers","year":"1994","journal-title":"Med. Microbiol. Immunol. (Berl.)"},{"key":"10.1016\/j.addr.2004.02.004_BIB20","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.4049\/jimmunol.166.5.3589","article-title":"Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine","volume":"166","author":"Polakos","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB21","first-page":"239","article-title":"The ISCOM technology","volume":"vol. 42","author":"L\u00f6vgren-Bengtsson","year":"2000"},{"key":"10.1016\/j.addr.2004.02.004_BIB22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0022-1759(87)90447-9","article-title":"Antigenic presentation of small molecules and peptides conjugated to a preformed ISCOM as carrier","volume":"98","author":"Lovgren","year":"1987","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.addr.2004.02.004_BIB23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0272-0590(88)90288-6","article-title":"Local reactions of the saponin Quil A and a Quil A containing ISCOM measles vaccine after intramuscular injection of rats: a comparison with the effect of DPT-polio vaccine","volume":"10","author":"Speijers","year":"1988","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.addr.2004.02.004_BIB24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2249.1995.tb06634.x","article-title":"Antigen presentation by naive macrophages, dendritic cells and B cells to primed T lymphocytes and their cytokine production following exposure to immunostimulating complexes","volume":"102","author":"Villacres-Eriksson","year":"1995","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-3083.1992.tb03225.x","article-title":"Antigen-specific increases in the number of splenocytes expressing MHC class II molecules following restimulation with antigen in various physical forms","volume":"36","author":"Bergstr\u00f6m-Mollaoglu","year":"1992","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1348-0421.1992.tb01657.x","article-title":"Interactions between immune-stimulating complexes (ISCOMs) and peritoneal mononuclear leucocytes","volume":"36","author":"Watson","year":"1992","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2249.1993.tb06507.x","article-title":"The induction of cell-associated and secreted IL-1 by ISCOMs, matrix or micelles in murine splenic cells","volume":"93","author":"Villacres-Eriksson","year":"1993","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB28","series-title":"Induction of immune response by ISCOMs","author":"Villacres-Eriksson","year":"1993"},{"key":"10.1016\/j.addr.2004.02.004_BIB29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/cyto.1996.0139","article-title":"Immunomodulation by Quillaja saponaria adjuvant formulations: in vivo stimulation of interleukin 12 and its effects on the antibody response","volume":"9","author":"Villacres-Eriksson","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.addr.2004.02.004_BIB30","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.4049\/jimmunol.162.9.5536","article-title":"Immune-stimulating complexes induce an IL-12-dependent cascade of innate immune responses","volume":"162","author":"Smith","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1006\/cimm.1998.1278","article-title":"Internalization of ISCOM-borne antigens and presentation under MHC class I or class II restriction","volume":"185","author":"Villacres","year":"1998","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB32","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/BF00914308","article-title":"Inflammatory response and antigen localization following immunization with influenza virus ISCOMs","volume":"13","author":"Watson","year":"1989","journal-title":"Inflammation"},{"key":"10.1016\/j.addr.2004.02.004_BIB33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1046\/j.1365-3083.1996.d01-29.x","article-title":"Kinetics, localization and isotype profile of antibody responses to immune stimulating complexes (ISCOMs) containing human influenza virus envelope glycoproteins","volume":"43","author":"Sjolander","year":"1996","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/cimm.1997.1088","article-title":"ISCOMs containing purified Quillaja saponins upregulate both Th1-like and Th2-like immune responses","volume":"177","author":"Sjolander","year":"1997","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB35","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0264-410X(96)00288-5","article-title":"Kinetics, localization and cytokine profile of T cell responses to immune stimulating complexes (ISCOMs) containing human influenza virus envelope glycoproteins","volume":"15","author":"Sjolander","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2004.02.004_BIB36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0171-2985(81)80072-1","article-title":"Frequencies of background immunoglobulin-secreting cells in mice as a function if organ, age, and immune status","volume":"158","author":"Benner","year":"1981","journal-title":"Immunobiology"},{"key":"10.1016\/j.addr.2004.02.004_BIB37","first-page":"1","article-title":"The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation","volume":"46","author":"Benner","year":"1981","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB38","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/jlb.64.6.713","article-title":"ISCOMs: an adjuvant with multiple functions","volume":"64","author":"Sjolander","year":"1998","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.addr.2004.02.004_BIB39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1084\/jem.176.1.119","article-title":"Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition","volume":"176","author":"van Binnendijk","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2004.02.004_BIB40","first-page":"15","article-title":"New concepts about atopic dermatitis","volume":"48","author":"Sosa Vazquez","year":"2001","journal-title":"Rev. Alergia Mex."},{"key":"10.1016\/j.addr.2004.02.004_BIB41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.1984.tb00488.x","article-title":"T-cell helper circuits","volume":"79","author":"McNamara","year":"1984","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.addr.2004.02.004_BIB42","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0008-8749(90)90217-F","article-title":"Effect of ISCOMs and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with ISCOMs and\/or matrix","volume":"129","author":"Fossum","year":"1990","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB43","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-3083.1992.tb02956.x","article-title":"Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus ISCOMs","volume":"36","author":"Villacres-Eriksson","year":"1992","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/expr.1993.1016","article-title":"Plasmodium falciparum: the immune response in rabbits to the clustered asparagine-rich protein (CARP) after immunization in Freund's adjuvant or immunostimulating complexes (ISCOMs)","volume":"76","author":"Sjolander","year":"1993","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.addr.2004.02.004_BIB45","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0684.1998.tb00226.x","article-title":"The role of type-1 and type-2 T-helper immune responses in HIV-1 vaccine protection","volume":"27","author":"Heeney","year":"1998","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.addr.2004.02.004_BIB46","series-title":"New Vaccine Technology","first-page":"274","article-title":"Chapter 16 biological aspects and prospects for adjuvants and delivery systems","author":"Morein","year":"1999"},{"key":"10.1016\/j.addr.2004.02.004_BIB47","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0165-2427(96)05697-8","article-title":"Novel adjuvants and vaccine delivery systems","volume":"54","author":"Morein","year":"1996","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.addr.2004.02.004_BIB48","first-page":"301","article-title":"Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens","volume":"59","author":"Lycke","year":"1986","journal-title":"Immunology"},{"key":"10.1016\/j.addr.2004.02.004_BIB49","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2249.1990.tb05467.x","article-title":"An experimental influenza subunit vaccine (ISCOM): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration","volume":"82","author":"L\u00f6vgren","year":"1990","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB50","first-page":"33","article-title":"ISCOM, a delivery system for parenteral and mucosal vaccination","volume":"92","author":"Morein","year":"1998","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.addr.2004.02.004_BIB51","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-3083.1988.tb02397.x","article-title":"Cellular immune responses in the murine lung to local immunization with influenza A virus glycoproteins in micelles and immunostimulatory complexes (ISCOMs)","volume":"27","author":"Jones","year":"1988","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB52","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2567.1998.00539.x","article-title":"Antigen detection in vivo after immunization with different presentation forms of rabies virus antigen: II. Cellular, but not humoral, systemic immune responses against rabies virus immune-stimulating complexes are macrophage dependent","volume":"94","author":"Claassen","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.addr.2004.02.004_BIB53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0264-410X(91)90269-C","article-title":"Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (ISCOM)","volume":"9","author":"Thapar","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2004.02.004_BIB54","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0165-2478(98)00136-9","article-title":"Oral vaccination with immune stimulating complexes","volume":"65","author":"Mowat","year":"1999","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.addr.2004.02.004_BIB55","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0167-5699(91)90133-E","article-title":"ISCOMs\u2014a novel strategy for mucosal immunization?","volume":"12","author":"Mowat","year":"1991","journal-title":"Immunol. Today"},{"key":"10.1016\/j.addr.2004.02.004_BIB56","first-page":"527","article-title":"Immune-stimulating complexes as adjuvants for inducing local and systemic immunity after oral immunization with protein antigens","volume":"80","author":"Mowat","year":"1993","journal-title":"Immunology"},{"key":"10.1016\/j.addr.2004.02.004_BIB57","series-title":"Immune Stimulating Complexes as Vectors for Oral Immunization","author":"Mowat","year":"1994"},{"key":"10.1016\/j.addr.2004.02.004_BIB58","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/(SICI)1521-4141(199906)29:06<1774::AID-IMMU1774>3.0.CO;2-1","article-title":"The mucosal adjuvant effects of cholera toxin and immune-stimulating complexes differ in their requirement for IL-12, indicating different pathways of action","volume":"29","author":"Grdic","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB59","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s004300050092","article-title":"Induction of antibody responses in the common mucosal immune system by respiratory syncytical virus immunostimulating complexes","volume":"187","author":"Hu","year":"1999","journal-title":"Med. Microbiol. Immunol. (Berl.)"},{"key":"10.1016\/j.addr.2004.02.004_BIB60","first-page":"110","article-title":"Vaccination against herpesvirus, fiction or reality?","volume":"80","author":"Morein","year":"1991","journal-title":"Scand. J. Infect. Dis. Suppl."},{"key":"10.1016\/j.addr.2004.02.004_BIB61","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2249.1998.00650.x","article-title":"The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses","volume":"113","author":"Hu","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0165-2427(97)00067-6","article-title":"ISCOM vaccine against contagious bovine pleuropneumonia (CBPP). 1. Biochemical and immunological characterization","volume":"59","author":"Abusugra","year":"1997","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.addr.2004.02.004_BIB63","first-page":"5","article-title":"ISCOM is an efficient mucosal delivery system for Mycoplasma mycoides subsp. mycoides (MmmSC) antigens inducing high mucosal and systemic antibody responses","volume":"23","author":"Abusugra","year":"1999","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.addr.2004.02.004_BIB64","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0165-2427(98)00171-8","article-title":"A mucosal IgA response, but no systemic antibody response, is evoked by intranasal immunisation of dogs with Echinococcus granulosus surface antigens ISCOMs","volume":"65","author":"Carol","year":"1998","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.addr.2004.02.004_BIB65","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-3024.1997.d01-197.x","article-title":"Intranasal immunization of mice with Echinococcus granulosus surface antigens ISCOMs evokes a strong immune response, biased towards glucidic epitopes","volume":"19","author":"Carol","year":"1997","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB66","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1439-0450.1980.tb02037.x","article-title":"Passive immunization of foals to prevent respiratory disease caused by equine herpesvirus type 2","volume":"27","author":"Belak","year":"1980","journal-title":"Zentralbl. Veterinarmed. B"},{"key":"10.1016\/j.addr.2004.02.004_BIB67","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1439-0450.1978.tb00737.x","article-title":"Isolation of equine herpesvirus type 2 from foals, showing respiratory symptoms","volume":"25","author":"Palfi","year":"1978","journal-title":"Zentralbl. Veterinarmed. B"},{"key":"10.1016\/j.addr.2004.02.004_BIB68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0378-1135(96)00032-6","article-title":"Equine herpesvirus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals: prevention of the bifactorial disease with EHV-2 immunostimulating complexes","volume":"51","author":"Nordengrahn","year":"1996","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.addr.2004.02.004_BIB69","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0264-410X(88)90105-3","article-title":"Control of infectious bovine rhinotracheitis in calves with a BHV-1 subunit-ISCOM vaccine","volume":"6","author":"Trudel","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2004.02.004_BIB70","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF01310477","article-title":"Characterization of purified gp51 from bovine leukemia virus integrated into ISCOM. Physicochemical properties and serum antibody response to the integrated gp51","volume":"120","author":"Merza","year":"1991","journal-title":"Arch. Virol."},{"key":"10.1016\/j.addr.2004.02.004_BIB71","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0264-410X(91)90245-2","article-title":"Protective effect of an ISCOM bovine virus diarrhoea virus (BVDV) vaccine against an experimental BVDV infection in vaccinated and non-vaccinated pregnant ewes","volume":"9","author":"Carlsson","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2004.02.004_BIB72","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0264-410X(89)90004-2","article-title":"Experimental polyvalent ISCOMs subunit vaccine induces antibodies that neutralize human and bovine respiratory syncytial virus","volume":"7","author":"Trudel","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2004.02.004_BIB73","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0264-410X(92)90026-G","article-title":"Initiation of cytotoxic T-cell response and protection of Balb\/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine","volume":"10","author":"Trudel","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2004.02.004_BIB74","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4049\/jimmunol.135.1.591","article-title":"Induction of protective immune response in cats by vaccination with feline leukemia virus ISCOM","volume":"135","author":"Osterhaus","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2004.02.004_BIB75","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0264-410X(89)90053-4","article-title":"Serological responses in cats vaccinated with FeLV ISCOM and an inactivated FeLV vaccine","volume":"7","author":"Osterhaus","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2004.02.004_BIB76","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0264-410X(92)90390-6","article-title":"Canine distemper virus ISCOMs induce protection in harbour seals (Phoca vitulina) against phocid distemper but still allow subsequent infection with phocid distemper virus-1","volume":"10","author":"Visser","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2004.02.004_BIB77","first-page":"551","article-title":"Long-standing protection of macaques against cell-free HIV-2 with a HIV-2 ISCOM vaccine","volume":"7","author":"Putkonen","year":"1994","journal-title":"J. Acquired Immune Defic. Syndr."},{"issue":"9","key":"10.1016\/j.addr.2004.02.004_BIB78","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/0264-410X(95)00262-Y","article-title":"Protective immunity induced in chicken by a single immunization with Mycoplasma gallisepticum immunostimulating complexes (ISCOMS)","volume":"14","author":"Sundquist","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2004.02.004_BIB79","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0264-410X(98)00390-9","article-title":"ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus","volume":"17","author":"Rimmelzwaan","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2004.02.004_BIB80","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1089\/aid.1992.8.1507","article-title":"Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell-associated homologous challenge","volume":"8","author":"Osterhaus","year":"1992","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.addr.2004.02.004_BIB81","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0264-410X(97)00084-4","article-title":"A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogen","volume":"15","author":"Davis","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2004.02.004_BIB82","doi-asserted-by":"crossref","first-page":"10803","DOI":"10.1073\/pnas.95.18.10803","article-title":"Beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques","volume":"95","author":"Heeney","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.addr.2004.02.004_BIB83","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1128\/JVI.73.4.3292-3300.1999","article-title":"Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance","volume":"73","author":"Verschoor","year":"1999","journal-title":"J. Virol."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X04000675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X04000675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T07:14:15Z","timestamp":1682666055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X04000675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":83,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0169409X04000675"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2004.02.004","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}